DECAAF II - Efficacy of DE-MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation
DECAAF II Logo DECAAF II Logo

Study Status

DECAAF II is a prospective, randomized, multi-center trial of patients with persistent Atrial Fibrillation (AF) and presence of atrial fibrosis. Enrollment is currently underway for this study. Interested patients should contact their local doctor about being involved in this trial.

Study Updates

As of January 3, 2019, we currently have 41 sites enrolling patients. By the end of January 2019, we expect 2 additional sites to be enrolling. We currently have 772 patients enrolled in the study.

 

 

 

 

 

 

 

(In accordance with the Americans with Disabilities Act, the information in this site is available in alternate formats upon request.)